Ready to explore partnership opportunities? We'd love to hear from you.
Whether you're interested in partnership opportunities, licensing our technology, or exploring co-development options, we're here to help.
Vaughan, Ontario
We typically respond within 24-48 hours
Common questions about partnering with Aerasyn
We offer multiple partnership pathways including licensing agreements, co-development collaborations, strategic alliances, and acquisition discussions. Each partnership is tailored to meet the unique needs and goals of our partners.
We focus on psychedelic therapeutics for neuropsychiatric conditions including treatment-resistant depression, PTSD, and anxiety disorders. Our platform spans discovery, delivery systems, and manufacturing.
Partners gain access to our proprietary platform technology, extensive IP portfolio (21+ patents), vertically integrated capabilities, and a team with deep pharmaceutical and biotech expertise—all while benefiting from our capital-efficient structure.
Initial responses are typically provided within 24-48 hours. From there, we work to understand your organization's needs and can often move to exploratory discussions within 1-2 weeks. The overall timeline varies based on the complexity of the partnership structure.
Yes, we actively collaborate with academic institutions on research initiatives, licensing of novel discoveries, and co-development of promising therapeutic candidates. We welcome inquiries from researchers and institutions in relevant fields.
Join us in pioneering the next generation of psychedelic therapeutics. Together, we can make a meaningful difference for patients in need.